We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$195M
1-Year Est. Return
51.17%
This Fund
S&P 500
This Quarter
Est. Return
-11.25%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$164M
AUM Growth
-$35.5M
(-18%)
Cap. Flow
-$9.16M
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
74.41%
Holding
106
New
32
Increased
9
Reduced
11
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.31M |
| 2 |
Consolidated Edison
ED
|
+$1.58M |
| 3 |
American Electric Power
AEP
|
+$1.57M |
| 4 |
Dominion Energy
D
|
+$1.56M |
| 5 |
Alliant Energy
LNT
|
+$1.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$6.22M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$4.54M |
| 3 |
Kura Oncology
KURA
|
+$2.21M |
| 4 |
Morgan Stanley
MS
|
+$1.94M |
| 5 |
SPDR Gold Trust
GLD
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.91% |
| 2 | Utilities | 9.24% |
| 3 | Consumer Staples | 3.5% |
| 4 | Financials | 2.86% |
| 5 | Industrials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Blackrock
BLK
$176B
| $528K | 0.32% |
700
| – | – |
|
52
Eastman Chemical
EMN
$8.42B
| $496K | 0.3% |
4,500
| – | – |
|
|
TRIL
53
DELISTED
Trillium Therapeutics Inc.
TRIL
| $460K | 0.28% |
+42,800
| New | +$529K |
|
54
PepsiCo
PEP
$190B
| $424K | 0.26% |
3,000
| – | – |
|
55
Medtronic
MDT
$112B
| $413K | 0.25% |
3,500
| – | – |
|
56
ExxonMobil
XOM
$634B
| $391K | 0.24% |
7,000
-7,299
| -51% | -$383K |
|
57
Intel
INTC
$513B
| $384K | 0.23% |
6,000
| – | – |
|
58
Berkshire Hathaway Class B
BRK.B
$1.13T
| $345K | 0.21% |
1,350
| – | – |
|
59
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
| $344K | 0.21% |
9,468
| – | – |
|
60
Coca-Cola
KO
$375B
| $343K | 0.21% |
6,502
| – | – |
|
61
Dow Inc
DOW
$21.2B
| $339K | 0.21% |
5,300
| – | – |
|
62
Merck
MRK
$318B
| $331K | 0.2% |
4,506
+1,362
| +43% | +$100K |
|
63
iShares Mortgage Real Estate ETF
REM
$543M
| $307K | 0.19% |
8,702
-30
| -0.3% | -$1K |
|
64
Pfizer
PFE
$153B
| $282K | 0.17% |
7,782
+2,282
| +41% | +$81K |
|
65
Biogen
BIIB
$30.7B
| $280K | 0.17% |
1,000
| – | – |
|
66
Sysco
SYY
$40.3B
| $276K | 0.17% |
3,500
| – | – |
|
|
TWTR
67
DELISTED
Twitter, Inc.
TWTR
| $258K | 0.16% |
+4,050
| New | +$248K |
|
68
CVS Health
CVS
$122B
| $248K | 0.15% |
3,300
-6,502
| -66% | -$474K |
|
69
SL Green Realty
SLG
$3.99B
| $245K | 0.15% |
+3,500
| New | +$236K |
|
70
National Fuel Gas
NFG
$7.65B
| $225K | 0.14% |
+4,500
| New | +$204K |
|
71
Axos Financial
AX
$5.68B
| $207K | 0.13% |
+4,400
| New | +$198K |
|
72
BlackRock Limited Duration Income Trust
BLW
$493M
| $182K | 0.11% |
10,871
-645
| -6% | -$10.3K |
|
73
BGC Group
BGC
$4.89B
| $164K | 0.1% |
34,052
| – | – |
|
|
EVM
74
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $158K | 0.1% |
13,579
| – | – |
|
75
Catheter Precision
VTAK
$1.01M
| $57K | 0.03% |
1
| – | – |
|
Similar funds
WM
CPI
RAM
MHFA
EWA
SC
KIM
CPRPA
Alethea Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Alethea Capital Management held 106 positions worth $164M, down 18% from $199M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Alethea Capital Management withdrew a net $9.16M in Q1 2021, closing 29 positions and reducing 11 holdings. Its most notable exit was Kura Oncology, an estimated $2.21M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 68% a quarter earlier, followed by Utilities and Consumer Staples.
Against the trend, Alethea Capital Management opened a new position in iShares 20+ Year Treasury Bond ETF worth $2.16M.
- Alethea Capital Management's largest Q1 2021 buy was iShares 20+ Year Treasury Bond ETF: 15,959 shares worth $2.16M.
- Alethea Capital Management added most to Procter & Gamble in Q1 2021, an estimated $1.52M increase.
- Alethea Capital Management's biggest Q1 2021 reduction was Capital One, cutting an estimated $6.22M.
- Alethea Capital Management fully exited Kura Oncology in Q1 2021, selling an estimated $2.21M.
- Alethea Capital Management's ten largest holdings make up 74% of its $164M portfolio in Q1 2021.
- Alethea Capital Management opened 32 new positions and closed 29 in Q1 2021.
- Alethea Capital Management's portfolio value fell 18% quarter-over-quarter to $164M.
Based on Alethea Capital Management's 13F filing for Q1 2021, filed 14 May 2021.